Navigation Links
Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen
Date:12/14/2011

BARCELONA, Spain, December 14, 2011 /PRNewswire/ --

The Contract Research Organization Kymos Pharma Services -specialised in analysis for the pharmaceutical, fine chemicals, biotechnological, veterinary, cosmetic and nutraceuticals sectors- has signed an agreement with the French multinational group Ipsen to take in a team of eight scientists from Ipsen R&D Centre in Sant Feliu de Llobregat (Barcelona).

For Kymos -with headquarters in Barcelona Science Park (PCB) and celebrating its 10th anniversary this year- this agreement allows the creation of an innovative area of R&D services in the field of bio molecules and biosimilars. Kymos will carry out this activity in a new immunology laboratory that will be opened in the PCB in early January 2012, conducting regulatory development projects for biotech companies.

"This new alliance consolidates the company's growth plan. The agreement also speeds up our international expansion plans, thus our company will be the only Spanish CRO and one of the few European ones that will be able to offer comprehensive services for biotech companies according to Good Laboratory Practices and Good Manufacturing Practices," says Joan Puig, strategic general manager of Kymos.  

About KymosPharma Services

Kymos Pharma Services is a CRO located in the PCB that was created in 2001 by a group of professionals with over 10 years of experience in R&D of pharmaceutical companies. The company is focused on comprehensive analytical development studies for pharmaceutical and related sectors, as well as on bioanalysis of preclinical and clinical studies of small molecules. At present, its financial turnover exceeds 2.5 million Euros, with a staff of 35 professionals and direct activities in Portugal and Italy. The company has over 80 clients, including the main Spanish pharmaceutical companies and clients from several countries such as France, Great Britain and Switzerland.

About Ipsen

Ipsen is a French biotechnology multinational group with sales of 1,100 million Euros that is listed on the Euronext stockmarket of Paris. It has 4,500 employees worldwide with offices in 50 countries and products sold in over 100.  As a leader in the biotech sector, Ipsen assigns 20% of its profits to R+D focused on the development of peptides and proteins in the therapeutic areas of neurology, endocrinology, oncology and haematology.  



 


'/>"/>
SOURCE Kymos Pharma Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
2. IPC The Hospitalist Company, Inc. to Report Third Quarter 2009 Results
3. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
4. IPC The Hospitalist Company, Inc. to Present at the 2009 Annual Credit Suisse Health Care Conference
5. Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities New Ideas for the New Year Conference on Thursday, January 14th
6. RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business
7. QuantaLife, a New Life Science Tool Company, Receives NIH Grant
8. RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms From BD
9. IPC The Hospitalist Company, Inc. to Report Fourth Quarter 2010 Results
10. Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company
11. LaVoie Group Wins Gold Mercury Award For Medical Device Company, Alphatec Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):